Granting funds. 1.1 On the basis of the grant application “Development of innovative cancer immunotherapies based on Hookipa’s Vaxwave® technology,” which was received via eCall on 10/01/2014, and on the basis of the expert decision of the advisory board in the 12/03/2014 meeting, funding will be granted for the following project: Project number: 849137 eCall number: 5040485 Project name (subject-matter of Contract): Program: General Program Österreichische Tel +43 (0)5 7755 — 0 UniCredit Bank Austria AG Forschungsförderungsgesellschaft mbH Fax +43 (0)5 7755 — 97900 Account no. 10216727200, Routing no. 12000 Xxxxxxxxxxx 0 xxx.xxx.xx, xxxxxx@xxx.xx IBAN XX00 0000 0000 0000 0000 1090 Vienna FN 252263.a Commercial Court Vienna SWIFT BKAUATVVW
Appears in 2 contracts
Samples: Funding Contract (HOOKIPA Pharma Inc.), Funding Contract (HOOKIPA Pharma Inc.)
Granting funds. 1.1 On the basis of the grant application “Development of innovative cancer immunotherapies based on Hookipa’s Vaxwave® technology,” which was received via eCall on 10/01/2014, and on the basis of the expert decision of the advisory board in the 12/03/2014 meeting, funding will be granted for the following project: Project number: 849137 eCall number: 5040485 Project name (subject-matter of Contract): Program: General Program Österreichische Tel +43 (0)5 7755 — 0 UniCredit Bank Austria AG Forschungsförderungsgesellschaft mbH Fax +43 (0)5 7755 — 97900 Account no. 10216727200, Routing no. 12000 Xxxxxxxxxxx 0 xxx.xxx.xx, xxxxxx@xxx.xx IBAN XX00 0000 0000 0000 0000 1090 Vienna FN 252263.a Commercial Court Vienna 000000x Xxxxxxxxxx Xxxxx Xxxxxx SWIFT BKAUATVVWXXXXXXXX
Appears in 2 contracts
Samples: Funding Contract (HOOKIPA Pharma Inc.), Funding Contract (HOOKIPA Pharma Inc.)
Granting funds.
1.1 On the basis of the grant application “Development of innovative cancer immunotherapies based on Hookipa’s Vaxwave® technology,” which was received via eCall on 10/01/2014, and on the basis of the expert decision of the advisory board in the 12/03/2014 meeting, funding will be granted for the following project: Project number: 849137 eCall number: 5040485 Project name (subject-matter of Contract): Program: General Program Österreichische Tel +43 (0)5 7755 — 0 UniCredit Bank Austria AG Forschungsförderungsgesellschaft mbH Fax +43 (0)5 7755 — 97900 Account no. 10216727200, Routing no. 12000 Xxxxxxxxxxx 0 xxx.xxx.xx, xxxxxx@xxx.xx IBAN XX00 0000 0000 0000 0000 1090 Vienna FN 252263.a 252263a Commercial Court Vienna SWIFT BKAUATVVWXXXXXXXX
Appears in 1 contract
Granting funds.
1.1 On the basis of the grant application “Development of innovative cancer immunotherapies based on Hookipa’s Vaxwave® technology,” which was received via eCall on 10/01/2014, and on the basis of the expert decision of the advisory board in the 12/03/2014 meeting, funding will be granted for the following project: Project number: 849137 eCall number: 5040485 Project name (subject-matter of Contract): Program: General Program Österreichische Tel +43 (0)5 7755 — 0 UniCredit Bank Austria AG Forschungsförderungsgesellschaft mbH Fax +43 (0)5 7755 — 97900 Account no. 10216727200, Routing no. 12000 Xxxxxxxxxxx 0 xxx.xxx.xx, xxxxxx@xxx.xx IBAN XX00 0000 0000 0000 0000 1090 Vienna FN 252263.a Commercial Court Vienna SWIFT BKAUATVVWBKAUATVVW
Appears in 1 contract